Unlocking the combined potential of SGLT2is and GLP-1 RAs for organ protection

13:00 – 13:10Welcome and introductionsTBC
13:10 – 13:25SGLT2is and GLP-1 RAs: Defined mechanisms, combined impact on cellular healthTBC
13:25 – 13:40Turning the cogs: Clinical evidence of SGLT2is and
GLP-1 RAs for kidney protection
TBC
13:40 – 13:55Unlocking the potential of SGLT2is and GLP-1 RAs for CV protectionTBC
13:55 – 14:25Looking to the future: The combined potential for SGLT2is and GLP-1 RAs to improve CV, renal, and metabolic healthAll faculty
14:25 – 14:30Summary and closeTBC
AstraZeneca logo